Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design
Article in Future Oncology (January 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Future Oncology (January 2024)
Article in Journal of Cancer Research and Clinical Oncology (January 2024)
Article in BMC Cancer (December 2023)